Deaths after COVID vaccination doubled to 180 in 2 weeks, shows report
SECTIONS
Share
Synopsis
According to an analysis of the data as of March 20, of the 494 adverse events reported, 124 were deaths, 305 were serious events that required hospitalisation and 65 were severe events.
AP
The immunisation division of the health and family welfare ministry on Thursday put out the causality assessment results of the 13 cases that were assessed over the past one month.
The number of deaths following Covid-19 vaccinations in India doubled to 180 as of March 29 from about two weeks earlier, according to a presentation made to the National Adverse Events Following Immunisation (AEFI) committee. There were also 617 serious and severe adverse events recorded in this period, the presentation by the health ministry’s Immunisation Technical Support Unit (ITSU) showed. The number of deaths after the Covid-19 vaccination drive recorded by the health ministry was 89 as of March 16.
NEW DELHI: India has no provision of compensation for recipients of Covid-19 vaccine in case of any side-effects or medical complications (adverse events) due to inoculation though treatment is free in public health facilities.
In a reply to a question in Parliament, the health ministry said, “There is no provision of compensation for recipients of Covid-19 vaccine against any kind of side-effects or medical complications.” While the government’s purchase order with vaccine-makers says the pharmaceutical firms will be liable for all adversities and refuses to indemnify them against any casualty, individuals will have to go to court to seek damages in case of serious adverse events, a senior official said.
Govt: No provision to compensate the vaccinated in case of adverse events
Govt: No provision to compensate the vaccinated in case of adverse events
TNN / Updated: Apr 6, 2021, 08:58 IST
India on April 6, 2021)
New Delhi: India has no provision of compensation for
recipients of
adverse events) due to inoculation though treatment is free in public health facilities.
In a reply to a question in Parliament, the health ministry said, “There is no provision of compensation for recipients of Covid-19 vaccine against any kind of side-effects or medical complications.” While the government’s purchase order with vaccine-makers says the pharmaceutical firms will be liable for all adversities and refuses to indemnify them against any casualty, individuals will have to go to court to seek damages in case of serious adverse events, a senior official said.
Bharat Biotech mulls booster dose six months after second shot of Covid vaccine
SECTIONS
Share
Synopsis
The company is studying administration of a booster dose in a separate Phase-2 trial. It has approached the Subject Expert Committee (SEC) under India s drug regulator with a proposal to administer the booster dose after six months of the second dose.
Bharat Biotech, the maker of Covaxin vaccine, is evaluating the option of adding a booster dose to its two-shot jab, amid concerns that emerging variants may weaken the effectiveness of vaccines designed to fight against older strains of coronavirus, a government official said.